Cetuximab for the treatment of advanced non-small-cell lung cancer [ID9]

  • Discontinued
  • GID-TAG395

Documents

Documents created during the development process.

Lung cancer (non-small-cell) - cetuximab: final scope

Lung cancer (non-small-cell) - cetuximab: final matrix

Lung cancer (non-small-cell) - cetuximab: Institute's response to consultees and commentator comments on the draft scope and provisional matrix

Lung cancer (non-small-cell) - cetuximab: final scope (superseded)

Lung cancer (non-small-cell) - cetuximab: final matrix (superseded)

Lung cancer (non-small-cell) - cetuximab: Institute's response to consultee and commentator comments on the draft scope (superseded)

Lung cancer (non-small-cell) - cetuximab: Institute's response to consultee and commentator comments on the provisional matrix (superseded)

Lung cancer (non-small-cell) - cetuximab: email sent to consultees and commentators updating them on the status of this appraisal

Lung cancer (non-small-cell) - cetuximab: 9 March 2009, email sent to consultees and commentators regarding the delay to this appraisal

Lung cancer (non-small-cell) - cetuximab: final scope

Lung cancer (non-small-cell) - cetuximab: final matrix of consultees and commentators (superseded)

Lung cancer (non-small-cell) - cetuximab: comments on the draft scope

Lung cancer (non-small-cell) - cetuximab: draft scope

Lung cancer (non-small-cell) - cetuximab: comments on the draft matrix

Lung cancer (non-small-cell) - cetuximab: draft matrix of consultees and commentators